From: OncLive <edigest@onclive.com>
Sent: <Variable Day of week, Month day, 2020 Time AM or PM>
To: <Variable attendee email address>
Subject: Live Broadcast Invitation: Learn About XPOVIO®
No Images? Click here
|
|
|
This promotional program is sponsored by Paratek Pharmaceuticals, Inc and it is not eligible for continuing medical education credits.
|
|
|
LIVE BROADCAST CONFIRMATION
|
|
|
Dear [Full Name],
We are pleased to confirm your registration to view this Live Broadcast on
retooling tetracyclines for 21st century challenges. Thank you for your
participation!
Program: Retooling Tetracyclines for 21st Century Challenges
Date: [Event Date]
Time: [Event Time][Event Timezone]
To view the broadcast on [Event Date], please click here or the button below.
|
|
|
Kerry Laplante, PharmD, FCCP, FIDSA
Professor of Pharmacy University of Rhode Island, Kingston, RI
Adjunct Professor of Medicine Brown University, Providence, RI
Director of the Rhode Island Infectious Diseases Fellowship and Research Programs
|
|
|
Abhay Dhand, MD
Director, Transplant Infectious Diseases Westchester Medical Center, Valhalla, NY
Associate Professor of Medicine New York Medical College, Valhalla, NY
|
|
|
In this Live Broadcast, Retooling Tetracyclines for 21st Century Challenges, our expert faculty will:
|
|
|
Review the historical
background on tetracycline
discovery, emerging resistance,
mechanism of action, and their
spectrum of activity.
|
|
|
|
|
Compare pharmacokinetic and pharmacodynamic similarities and differences for tetracycline antibiotics.
|
|
|
|
|
Discuss the clinical data supporting tetracycline use for common bacterial infections including complicated intra-abdominal infections, skin and skin structure infections, and community acquired bacterial pneumonia.
|
|
|
|
|
Identify applications for tetracycline-class antibiotics after assessing risks and benefits given a patient case.
|
|
|
|
|
© 2020 Paratek Pharmaceuticals, Inc. All rights reserved.
PARATEK® and the hexagon logo are registered trademarks of
Paratek Pharmaceuticals, Inc.
US-NUA-0xxx 0x/20
|
|
|
|
|
Contagion® – an MJH Life Sciences® brand
Copyright 2020 © Intellisphere, LLC
2 Clarke Drive | Suite 100 | Cranbury, NJ | 08512
Preferences | Unsubscribe
|
|
|